The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites.

We designed the N-methylanthranilic-desferrioxamine (MA-DFO) as a fluorescent iron (III) chelator with improved membrane permeation properties. Upon binding of iron (III), MA-DFO fluorescence is quenched, thus allowing traceability of drug-iron (III) interactions. MA-DFO is well tolerated by mammali...

תיאור מלא

מידע ביבליוגרפי

הוצא לאור ב:	J Clin Invest
Principais autores:	Loyevsky, M, Lytton, S D, Mester, B, Libman, J, Shanzer, A, Cabantchik, Z I
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	American Society for Clinical Investigation 1993
נושאים:	Research Article
גישה מקוונת:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC330017/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8423220/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI116174
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!